ORIENT BIO Market Cap

ORIENT BIO has a market cap or net worth of 200.02 billion as of February 21, 2025. Its market cap has increased by 182.11% in one year.

Market Cap

200.02B

Enterprise Value

n/a

Revenue

59.09B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,780.00

Market Cap Chart

Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 200.02B, an increase of 541.10%. That is a compound annual growth rate of 6.50%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	200.02B	9.05%
Dec 30, 2024	183.42B	154.86%
Dec 28, 2023	71.97B	-0.98%
Dec 29, 2022	72.68B	-49.75%
Dec 30, 2021	144.65B	-3.55%
Dec 30, 2020	149.97B	116.58%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	82.35T
Celltrion	37.80T
Yuhan	9,163.93B
SK Biopharmaceuticals	9,013.86B
SK bioscience	3,748.92B
Hanmi Pharm.	3,404.64B
Peptron	2,152.68B
Hanall Biopharma	1,985.31B

Market Cap Rankings